跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
SII TD-VAC - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
SII TD-VAC
Approved
STANDARD
SII TD-VAC
Serum Institute of India Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
20db4f15f311dff7
Company
Serum Institute of India Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
20db4f15f311dff7
Drug Approval Philippines Name
SII TD-VAC
Product Name
SII TD-VAC
Registration Number
BR-737
Brand Name
SII TD-VAC
Generic Name
Diphtheria and Tetanus Vaccine (Adsorbed)
Dosage Form
Suspension for Injection (IM)
Dosage Strength
Formulation: Each dose (0.5 mL) contains: Diphtheria Toxoid.........<5 Lf 2 2 IU) Tetanus Toxoid................<5 Lf( 40 IU) Adsorbed on Aluminum Phosphate, Al3+.....................< 1.25 mg
Manufacturer
Serum Institute of India Pvt. Ltd.
Importer
Medical Vaccines Online Deliveries
Distributor
Medical Vaccines Online Deliveries
Company Detail Path
/organization/serum-institute-of-india-pvt-ltd
Issuance Date
02 June 2022
Expiry Date
27 April 2027
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
20db4f15f311dff7
Type
Standard
Back to Philippines FDA Approvals